Your session is about to expire
How Do T Cells Kill Cancer Cells: What You Need To Know
Understanding CAR T-Cell Therapy
CAR T-cell therapy is an innovative treatment. It uses your own cells to fight cancer. This is a type of immunotherapy.
How does it work?
Doctors take some of your T-cells (a kind of white blood cell). They then change these cells in a lab. They add a special receptor called CAR (chimeric antigen receptor). These new "CAR T-cells" now can find and kill cancer cells better.
This process might sound complex, but think about it like this: Imagine giving tiny soldiers night vision goggles so they can see their enemy clearly in the dark.
What's next after creating these super-soldiers?
Once doctors have enough CAR T-cells, they put them back into your body. Now, they're ready to attack cancer cells directly! Remember, these are still your own cells - just made stronger and smarter.
In conclusion, CAR T-cell therapy offers hope for people with certain types of cancers that don't respond well to other treatments. It's cutting edge science used today!
Remember: Every patient's journey with this therapy will be different. Always talk with your doctor or medical team if you have questions or concerns.
Collecting and Manufacturing T Cells
Collecting T Cells
T cells are part of your immune system. They fight off infections and diseases. To collect them, doctors use a process called leukapheresis. In simple terms, blood is drawn from your body through an IV line. This blood goes into a machine that separates out the T cells.
Manufacturing T Cells
After collection, these T cells go to a lab. Here, they undergo modification to become CAR-T cells (Chimeric Antigen Receptor-T cells). Scientists introduce new genetic material into the T cell DNA using viral vectors - think of it as adding special instructions for the cell.
These modified CAR-T cells now have the ability to recognize and attack cancer cells specifically when infused back into your body. This whole process takes about 2-3 weeks before the engineered CAR-T cells are ready for infusion.
Remember: every patient’s treatment plan can vary based on their individual needs and medical history!
Infusing the CAR T Cells
Infusing the CAR T cells is a key step in CAR T cell therapy. This procedure involves re-introducing your modified T cells back into your body. CAR stands forChimeric Antigen Receptor. These are special receptors added to your T cells to help them recognize and fight cancer.
Before infusion, you might receive chemotherapy. This is not always the case but it's common. The aim of this 'prep' chemo is to make room for the new CAR T cells in your body. After this, the actual infusion takes place.
The process of infusion is simple and similar to getting a blood transfusion or IV drip. Your healthcare team connects you to an IV line through which they introduce the CAR T cells into your bloodstream. It usually lasts less than an hour.
It's crucial that you know that after infusion, these supercharged T-cells start their work immediately! They seek out cancer cells using their new capabilities and destroy them systematically.
Side Effects of Therapy
Physical Therapy: Mild discomfort or muscle soreness is common after sessions. Severe pain or injury is rare but possible if exercises are performed incorrectly. Regular communication with your therapist helps minimize risks.
Psychotherapy: Emotional distress often surfaces when discussing sensitive topics. You may feel worse before you feel better as part of the healing process. It's crucial to have a strong support system in place during this time.
Drug Therapy (Pharmacotherapy): Side effects vary widely based on the specific drug used, dosage, and duration of use. Common symptoms include nausea, headache, fatigue, and changes in appetite or weight among others.
It's important to remember that experiencing side effects does not mean therapy is ineffective; it's merely a response to treatment intervention which varies across individuals. Always discuss any concerns about side effects with your healthcare provider promptly for appropriate management strategies.
Related trials for Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome
Find Top Cancer Clinical Trials
Choose from over 30,000 active clinical trials.
Cytokine Release Syndrome (CRS)
Cytokine Release Syndrome (CRS) is a condition. It happens when your body releases too many cytokines. Cytokines are small proteins. They help cells communicate during immune responses.
You need to know that CRS often comes from cancer treatments. These include CAR-T cell therapy and monoclonal antibody drugs. Symptoms can be mild or severe, depending on the patient's health and treatment type.
Severe symptoms may require hospital care. They include high fever, difficulty breathing, and low blood pressure. Mild symptoms include nausea, headache, and fatigue.
Treatment for CRS depends on its severity as well as the underlying cause of the syndrome in each patient case individually.
Immune Effector Cell-associated Neurotoxicity Syndrome (ICANS)
Immune Effector Cell-associated Neurotoxicity Syndrome (ICANS)
Immune Effector Cell-associated Neurotoxicity Syndrome, or ICANS, is a medical condition. It happens after certain cancer treatments. These treatments use your body's immune cells to destroy cancer cells.
You might experience ICANS when you get CAR-T cell therapy. This therapy changes your T-cells, a type of white blood cell, in the lab. The changed T-cells then attack cancer cells in your body.
Symptoms often appear within days of treatment. They can include confusion, difficulty speaking, and seizures among others. Doctors have scales to measure these symptoms and determine if it's ICANS.
Treatment for ICANS involves managing symptoms and sometimes hospital care. Your doctor may give you medications like corticosteroids or tocilizumab to control inflammation in your brain.
Remember: Knowledge empowers! Understanding potential side effects helps you make informed decisions about treatment options.
Post-Therapy Precautions and Care
Post-Therapy Precautions
Avoid strenuous activities: Rest is essential post-therapy. Avoid heavy lifting or high-intensity exercise. Your body needs to recover.
Mind your diet: Some therapies may affect appetite or digestion. Stick to a balanced and nutritious diet.
Listen to your body: Notice any new symptoms? Report them to your healthcare provider immediately.
Post-Therapy Care
Regular follow-up visits with your healthcare provider are key. They assess progress and address concerns you may have.
Hydrate adequately: Water aids in healing and detoxification processes of the body after therapy sessions.
Physical activity: As recovery progresses, physical activity becomes important for maintaining strength and function within tolerable limits set by your physician.
Remember: Everyone's recovery journey differs significantly; patience plays an integral part in this process.
CAR T-Cell Therapy Approvals
CAR T-cell therapy is a revolution in cancer treatment. The FDA approves it. This approval means that the treatment has passed rigorous testing for safety and efficacy. Two types are currently approved: Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel).
Kymriah, by Novartis, was the first CAR T-cell therapy to gain FDA approval in 2017. It's used for certain types of B-cell lymphoma and acute lymphoblastic leukemia.
Yescarta, developed by Kite Pharma, received its FDA nod later in 2017. It specifically treats large B-Cell lymphomas after two or more other kinds of treatment haven’t worked.
Staying updated on approvals helps you understand your options better as a patient.